Info
Dr. Ravi Salgia from University of Chicago discusses his perspective on side effects of targeted therapies as compared with standard chemotherapy for patients with lung cancer.
8 anni fa
#alk, #cancergrace, #chemotherapy, #chicago, #effects, #egfr, #erlotinib, #gefitinib, #grace, #gracecast, #inhibitor, #iressa, #of, #ravi, #side, #tarceva, #targeted, #therapy, #toxicity, #university
Scopri di più
Cerca
